GlassScriptPhysician profile
Chanci Mascelli
NPI 1407470362
$800.32
in general payments reported to CMS, 2019-2025
18 companies · $87.13 in 2025
The $87.13 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $89.39 · 2022: $275 · 2023: $262 · 2024: $87.41 · 2025: $87.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $328.52 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $80.78 | 2022-2023 | Opdivo |
| Abbvie INC. | $67.85 | 2022-2025 | |
| Celgene Corporation | $44.67 | 2022-2023 | Reblozyl |
| Pfizer INC. | $39.86 | 2023-2025 | |
| Cardiovascular Systems INC. | $32.19 | 2021 | |
| Amgen INC. | $28.14 | 2022 | |
| Myovant Sciences INC. | $25.80 | 2021-2022 | |
| Genzyme Corporation | $18.36 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.81 | 2023 | Vpriv |
| Octapharma USA, INC. | $17.26 | 2023 | Panzyga |
| Epizyme, INC. | $16.47 | 2022 | |
| Mirati Therapeutics, INC. | $15.86 | 2023 | Krazati |
| Pharmacyclics LLC, An Abbvie Company | $15.14 | 2022 | |
| Janssen Biotech, INC. | $14.51 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.21 | 2023 | Keytruda |
| Emd Serono, INC. | $12.16 | 2022 | |
| Eisai INC. | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chanci Mascelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.